Tamiflu: A poster child for transparency in clinical trials?
Thursday 10 April saw the publication of the Cochrane systematic review on oseltamivir and zanamivir, or Tamiflu (Roche) and Relenza (GlaxoSmithKline)… Read more »
Thursday 10 April saw the publication of the Cochrane systematic review on oseltamivir and zanamivir, or Tamiflu (Roche) and Relenza (GlaxoSmithKline)… Read more »
“It is difficult to make informed decisions if publication bias and selective reporting are present” World Health Organization For years,… Read more »
Authors of study protocols in Systematic Reviews are now entitled to a 20% discount on the article processing charge (APC) for… Read more »
The first international stroke trial (IST) suggested that aspirin should be administered to stroke patients as soon as possible… Read more »
Unpublished research is a serious problem for evidence-based decision making in healthcare, and this was recently highlighted on… Read more »
BioMed Central recently convened some inaugural ‘threaded publications’ discussions in Oxford, UK. This post is an expanded… Read more »
More than a decade ago Altman and Chalmers envisaged a new way to publish clinical research. They proposed that, facilitated by… Read more »